Bridgeway Capital Management’s Minerva Surgical, Inc. Common Stock UTRS Stock Holding History

Bridgeway Capital Management’s Portfolio UTRS Stock Details UTRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,935	Closed	-$17.3K	–	1472
2023 Q1	$17.3K	Sell	3,935 -2,425	-38%	-$14.9K	﹤0.01%	1359
2022 Q4	$28.4K	Sell	6,360 -3,750	-37%	-$24.9K	﹤0.01%	1328
2022 Q3	$161K	Hold	10,110	–	–	﹤0.01%	1178
2022 Q2	$475K	Buy	10,110 +6,365	+170%	+$369K	0.01%	890
2022 Q1	$337K	Buy	3,745 +1,245	+50%	+$127K	0.01%	1043
2021 Q4	$257K	Buy	+2,500	New	+$355K	﹤0.01%	1127

Other funds holding UTRS

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

FRA

Frank Rimerman Advisors Palo Alto, California $1.77B AUM 41.18% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

CSS

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

Bridgeway Capital Management's UTRS Position: Q2 2023 in Review

Bridgeway Capital Management sold out of Minerva Surgical, Inc. Common Stock (UTRS) in Q2 2023, closing a stake of 3,935 shares — an estimated $17.3K sold.

Bridgeway Capital Management first reported a position in UTRS in Q4 2021 and held it in 6 quarters. The position peaked at $475K in Q2 2022. 17 funds tracked by Wall St. Rank hold UTRS as of Q2 2023.

Bridgeway Capital Management reported no remaining Minerva Surgical, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Bridgeway Capital Management sold 3,935 Minerva Surgical, Inc. Common Stock shares in Q2 2023, an estimated $17.3K.
Bridgeway Capital Management first reported a position in Minerva Surgical, Inc. Common Stock in Q4 2021 and held it in 6 quarters.
Bridgeway Capital Management's Minerva Surgical, Inc. Common Stock position peaked at $475K in Q2 2022.
17 funds tracked by Wall St. Rank held Minerva Surgical, Inc. Common Stock as of Q2 2023.

Based on Bridgeway Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.